Additionally, in the most recently accomplished comparative study by Ying Liu et al., the expression levels of IL-38 and underlying inflammatory mechanisms were quantitively investigated in patients with T2DM and the ones with no abnormality in glucose metabolism (as a control group). Here, IL1F10 is linked to type 2 diabetes mellitus.